Turkey : Pharmaceutical Sector Analysis
Pharmaceuticals are essential to achieve health outcomes, but are at the same time a major cost factor in every health system. From a patient perspective, access to pharmaceuticals is a proxy for the functioning of the health system. With increasin...
| Main Authors: | , |
|---|---|
| Format: | Report |
| Language: | English en_US |
| Published: |
Ankara, World Bank
2017
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/389721468310466052/Turkey-Pharmaceutical-sector-analysis http://hdl.handle.net/10986/28110 |
| Summary: | Pharmaceuticals are essential to achieve
health outcomes, but are at the same time a major cost
factor in every health system. From a patient perspective,
access to pharmaceuticals is a proxy for the functioning of
the health system. With increasing economic strength,
patients become more demanding with regard to access to
modern, sophisticated drugs and providers become more
aggressive in marketing those drugs. This paper reflects the
situation in the pharmaceutical sector in Turkey, identifies
critical issues, and discusses policy options based on
current trends and the overall policy objectives of the
Turkish government. This paper is structured as follows:
chapter one gives introduction; chapter two gives overall
policy objectives in the pharmaceutical sector in Turkey;
chapter three presents institutional and regulatory
framework; chapter four presents reimbursement rules;
chapter five focuses on governance issues in the
pharmaceutical sector; chapter six gives market overview;
chapter seven gives payment for pharmaceuticals in Turkey;
chapter eight presents prescribing practices - rational use
of medicines; and chapter nine gives conclusions and way forward. |
|---|